Novo Nordisk Announces Reimagine 5 Trial Results, CagriSema Achieves 12.4% Weight Loss

Article

--・Verified Binance official account

According to Wallstreetcn, Novo Nordisk announced results from the Reimagine 5 trial, and its CagriSema achieved 12.4% weight loss.

Disclaimer: Includes third-party opinions. No advice. Binance AI may be used without guarantee. See T&Cs.

2.8k

Join global crypto users on Binance Square

⚡️ Get latest and useful information about crypto.

💬 Trusted by the world’s largest crypto exchange.

👍 Discover real insights from verified creators.

Email / Phone number

Cookie Preferences